Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BeiGene’s ovarian cancer drug pamiparib gets conditional approval in China

pharmaceutical-technologyMay 11, 2021

Tag: BeiGene , ovarian cancer , pamiparib

PharmaSources Customer Service